Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy.
Montagna G, Mrdutt MM, Sun SX, Hlavin C, Diego EJ, Wong SM, Barrio AV, van den Bruele AB, Cabioglu N, Sevilimedu V, Rosenberger LH, Hwang ES, Ingham A, Papassotiropoulos B, Nguyen-Sträuli BD, Kurzeder C, Aybar DD, Vorburger D, Matlac DM, Ostapenko E, Riedel F, Fitzal F, Meani F, Fick F, Sagasser J, Heil J, Karanlik H, Dedes KJ, Romics L, Banys-Paluchowski M, Muslumanoglu M, Perez MDRC, Díaz MC, Heidinger M, Fehr MK, Reinisch M, Tukenmez M, Maggi N, Rocco N, Ditsch N, Gentilini OD, Paulinelli RR, Zarhi SS, Kuemmel S, Bruzas S, di Lascio S, Parissenti TK, Hoskin TL, Güth U, Ovalle V, Tausch C, Kuerer HM, Caudle AS, Boileau JF, Boughey JC, Kühn T, Morrow M, Weber WP. Montagna G, et al. Among authors: cabioglu n. JAMA Oncol. 2024 Apr 25:e240578. doi: 10.1001/jamaoncol.2024.0578. Online ahead of print. JAMA Oncol. 2024. PMID: 38662396
SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer.
Has Simsek D, Emiroglu S, Yilmaz R, Bayram A, Isik EG, Tukenmez M, Kuyumcu S, Dursun M, Muslumanoglu M, Cabioglu N. Has Simsek D, et al. Among authors: cabioglu n. Clin Nucl Med. 2022 Nov 1;47(11):e682-e688. doi: 10.1097/RLU.0000000000004340. Epub 2022 Jul 15. Clin Nucl Med. 2022. PMID: 35835147
Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
Cabıoğlu N, Karanlık H, Kangal D, Özkurt E, Öner G, Sezen F, Yılmaz R, Tükenmez M, Önder S, İğci A, Özmen V, Dinççağ A, Engin G, Müslümanoğlu M. Cabıoğlu N, et al. Ann Surg Oncol. 2018 Oct;25(10):3030-3036. doi: 10.1245/s10434-018-6575-6. Epub 2018 Jul 5. Ann Surg Oncol. 2018. PMID: 29978371
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes.
Özkurt E, Emiroğlu S, Cabioğlu N, Karanlık H, Önder S, Tükenmez M, İğci A, Özmen V, Müslümanoğlu M. Özkurt E, et al. Among authors: cabioglu n. Breast Care (Basel). 2022 Dec;17(6):554-560. doi: 10.1159/000525324. Epub 2022 Jun 2. Breast Care (Basel). 2022. PMID: 36590148 Free PMC article.
Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up.
Özkurt E, Tükenmez M, Güven E, Çelet Özden B, Öner G, Müslümanoğlu M, İğci A, Özmen V, Küçücük S, Cabioğlu N. Özkurt E, et al. Among authors: cabioglu n. Balkan Med J. 2018 Jan 20;35(1):84-92. doi: 10.4274/balkanmedj.2017.0029. Epub 2017 Sep 29. Balkan Med J. 2018. PMID: 28958980 Free PMC article.
Favorable Long-Term Outcome in Male Breast Cancer.
Özkurt E, Tükenmez M, Yılmaz R, Cabioğlu N, Müslümanoğlu M, Dinççağ AS, İğci A, Özmen V. Özkurt E, et al. Among authors: cabioglu n. Eur J Breast Health. 2018 Jul 1;14(3):180-185. doi: 10.5152/ejbh.2018.3946. eCollection 2018 Jul. Eur J Breast Health. 2018. PMID: 30123885 Free PMC article.
91 results